glp 1 agonist trade name GLP-1 analogs, new trend in obesity treatment, become even more effective < Pharma < Article glp 1 agonist trade name
Description
Plummer MP, Jones KL, Annink CE, et al
Importantly, as shown in a subset of patients, no significant cross-reaction was observed between anti-exenatide antibodies and human GLP-1 or glucagon
However, the lack of available evidence has limited researchers from making definitive conclusions on this potential association
Blackman, A
or via the intestinal lumen
Now, the drug is also indicated to prevent kidney disease worsening, kidney failure, and death due to cardiovascular disease in adults with type 2 diabetes and chronic kidney disease (CKD)
